相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ROS in cancer therapy: the bright side of the moon
Bruno Perillo et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
The Fluorine Effect in Zwitterionic Half-Sandwich Iridium(III) Anticancer Complexes
Yanjing Yang et al.
INORGANIC CHEMISTRY (2020)
New ruthenium polypyridyl complexes functionalized with fluorine atom or furan: Synthesis, DNA-binding, cytotoxicity and antitumor mechanism studies
Guang-Bin Jiang et al.
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2020)
Ruthenium (II) complexes with N, O-chelating proline and threonine ligands cause selective cytotoxicity by the induction of genomic instability, cell cycle arrest and apoptosis in breast and prostate tumor cells
Israel Higino de Sousa et al.
TOXICOLOGY IN VITRO (2020)
Effect of N,N Coordination and RuII Halide Bond in Enhancing Selective Toxicity of a Tyramine-Based RuII (p-Cymene) Complex
Arpan Mukherjee et al.
INORGANIC CHEMISTRY (2020)
Recent advances in cytotoxicity, cellular uptake and mechanism of action of ruthenium metallodrugs: A review
P. Sudhindra et al.
POLYHEDRON (2020)
Selective and high yield transformation of glycerol to lactic acid using NNN pincer ruthenium catalysts
Moumita Dutta et al.
CHEMICAL COMMUNICATIONS (2020)
Bifunctional ruthenium(ii) polypyridyl complexes of curcumin as potential anticancer agents
Shuang Li et al.
DALTON TRANSACTIONS (2020)
Cationic carboxylate and thioacetate ruthenium(II) complexes: synthesis and cytotoxic activity against anaplastic thyroid cancer cells
Denise Lovison et al.
DALTON TRANSACTIONS (2020)
Triphenylamine/carbazole-modified ruthenium(ii) Schiff base compounds: synthesis, biological activity and organelle targeting
Shujiao Chen et al.
DALTON TRANSACTIONS (2020)
Fluorescent half-sandwich phosphine-sulfonate iridium(III) and ruthenium (II) complexes as potential lysosome-targeted anticancer agents
Qing Du et al.
DYES AND PIGMENTS (2019)
Efficient Pincer-Ruthenium Catalysts for Kharasch Addition of Carbon Tetrachloride to Styrene
Kanu Das et al.
ADVANCED SYNTHESIS & CATALYSIS (2019)
Lysosome-Targeted Phosphine-Imine Half-Sandwich Iridium(III) Anticancer Complexes: Synthesis, Characterization, and Biological Activity
Yuliang Yang et al.
ORGANOMETALLICS (2019)
ROS-Mediated Cancer Cell Killing through Dietary Phytochemicals
Saranya NavaneethaKrishnan et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
N-Alkylation of Amines Catalyzed by a Ruthenium-Pincer Complex in the Presence of in situ Generated Sodium Alkoxide
Kanu Das et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2019)
Ferrocene-Appended Iridium(III) Complexes: Configuration Regulation, Anticancer Application, and Mechanism Research
Xingxing Ge et al.
INORGANIC CHEMISTRY (2019)
Design and synthesis of new ruthenium polypyridyl complexes with potent antitumor activity in vitro
Guang-Bin Jiang et al.
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2019)
Recent advances in ruthenium and platinum based supramolecular coordination complexes for antitumor therapy
Xiaoming Zhang et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2019)
Silk sericin induced pro-oxidative stress leads to apoptosis in human cancer cells
Jadi Praveen Kumar et al.
FOOD AND CHEMICAL TOXICOLOGY (2019)
Experimental and theoretical investigations of cyclometalated ruthenium(ii) complex containing CCC-pincer and anti-inflammatory drugs as ligands: synthesis, characterization, inhibition of cyclooxygenase and in vitro cytotoxicity activities in various cancer cell lines
Leila Tabrizi et al.
DALTON TRANSACTIONS (2019)
Zwitterionic and cationic half-sandwich iridium(iii) ruthenium(ii) complexes bearing sulfonate groups: synthesis, characterization and their different biological activities
Yanjing Yang et al.
DALTON TRANSACTIONS (2019)
Potential Nanomedicine Applications of Multifunctional Carbon Nanoparticles Developed Using Green Technology
Jadi Praveen Kumar et al.
ACS SUSTAINABLE CHEMISTRY & ENGINEERING (2018)
Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing PP-Chelating Ligands
JuanJuan Li et al.
INORGANIC CHEMISTRY (2018)
alpha-Diimines as Versatile, Derivatizable Ligands in Ruthenium(II) p-Cymene Anticancer Complexes
Lorenzo Biancalana et al.
INORGANIC CHEMISTRY (2018)
Imine-N-Heterocyclic Carbenes as Versatile Ligands in Ruthenium(II) p-Cymene Anticancer Complexes: A Structure-Activity Relationship Study
Yuliang Yang et al.
CHEMISTRY-AN ASIAN JOURNAL (2018)
Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents
Yuliang Yang et al.
INORGANIC CHEMISTRY (2018)
Potent Half-Sandwich Iridium(III) and Ruthenium(II) Anticancer Complexes Containing a PO-Chelated Ligand
Qing Du et al.
ORGANOMETALLICS (2018)
(Pyridin-2-yl)-NHC Organoruthenium Complexes: Antiproliferative Properties and Reactivity Toward Biomolecules (vol 37, pg 1575, 2018)
Sanam Movassaghi et al.
ORGANOMETALLICS (2018)
Reactive Oxygen Species: A Key Constituent in Cancer Survival
Seema Kumari et al.
BIOMARKER INSIGHTS (2018)
Iron(III) Pincer Complexes as a Strategy for Anticancer Studies
Aldo S. Estrada-Montano et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2017)
Tuning the cytotoxicity of ruthenium(II) para-cymene complexes by mono-substitution at a triphenylphosphine/phenoxydiphenylphosphine ligand
Lorenzo Biancalana et al.
DALTON TRANSACTIONS (2017)
Aminophosphine ligands as a privileged platform for development of antitumoral ruthenium(II) arene complexes
L. M. Broomfield et al.
DALTON TRANSACTIONS (2017)
Novel half-sandwich iridium(III) imino-pyridyl complexes showing remarkable in vitro anticancer activity
JuanJuan Li et al.
DALTON TRANSACTIONS (2017)
The development of anticancer ruthenium(II) complexes: from single molecule compounds to nanomaterials
Leli Zeng et al.
CHEMICAL SOCIETY REVIEWS (2017)
Neutron activation increases activity of ruthenium-based complexes and induces cell death in glioma cells independent of p53 tumor suppressor gene
Aline Monezi Montel et al.
BIOMETALS (2017)
Thiolato-bridged dinuclear arene ruthenium complexes and their potential as anticancer drugs
Julien Furrer et al.
COORDINATION CHEMISTRY REVIEWS (2016)
CF3 Derivatives of the Anticancer Ru(III) Complexes KP1019, NKP-1339, and Their Imidazole and Pyridine Analogues Show Enhanced Lipophilicity, Albumin Interactions, and Cytotoxicity
Stephanie W. Chang et al.
INORGANIC CHEMISTRY (2016)
Biodistribution of the novel anticancer drug sodium trans-Retrachloridobis(1H-indazole)ruthenate(III)] KP-1339/IT139 in nude BALB/c mice and implications on its mode of action
Anna K. Bytzek et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2016)
Ruthenium(II) Complexes with 2-Phenylimidazo[4,5-f][1,10] phenanthroline Derivatives that Strongly Combat Cisplatin-Resistant Tumor Cells
Leli Zeng et al.
SCIENTIFIC REPORTS (2016)
Noble metals in medicine: Latest advances
Serenella Medici et al.
COORDINATION CHEMISTRY REVIEWS (2015)
SHELXT - Integrated space-group and crystal-structure determination
George M. Sheldrick
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES (2015)
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
Suzanne Leijen et al.
INVESTIGATIONAL NEW DRUGS (2015)
Metallodrugs in Medicinal Inorganic Chemistry
Katja Dralle Mjos et al.
CHEMICAL REVIEWS (2014)
Influence of PPh3 moiety in the anticancer activity of new organometallic ruthenium complexes
Ruben Saez et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2014)
A Breast Cancer Stem Cell-Selective, Mammospheres-Potent Osmium(VI) Nitrido Complex
Kogularamanan Suntharalingam et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Mechanism of cellular accumulation of an iridium(III) pentamethylcyclopentadienyl anticancer complex containing a C,N-chelating ligand
Vojtech Novohradsky et al.
METALLOMICS (2014)
A dual-targeting, apoptosis-inducing organometallic half-sandwich iridium anticancer complex
Vojtech Novohradsky et al.
METALLOMICS (2014)
Potent Half-Sandwich Iridium(III) Anticancer Complexes Containing C∧I-Chelated and Pyridine Ligands
Zhe Liu et al.
ORGANOMETALLICS (2014)
Bioactive iridium and rhodium complexes as therapeutic agents
Chung-Hang Leung et al.
COORDINATION CHEMISTRY REVIEWS (2013)
Cationic arene ruthenium(II) complexes with chelating P-functionalized alkyl phenyl sulfide and sulfoxide ligands as potent anticancer agents
Gerd Ludwig et al.
DALTON TRANSACTIONS (2013)
Biological activity of neutral and cationic iridium(III) complexes with κP and κP,κS coordinated Ph2PCH2S(O)xPh (x=0-2) ligands
Gerd Ludwig et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
New, Highly Efficient, Simple, Safe, and Scalable Synthesis of [(Ph3P)3Ru(CO)(H)2]
Hamidreza Samouei et al.
ORGANOMETALLICS (2013)
Ruthenium(II) polypyridyl complexes and DNA-from structural probes to cellular imaging and therapeutics
Martin R. Gill et al.
CHEMICAL SOCIETY REVIEWS (2012)
Challenges and Opportunities in the Development of Organometallic Anticancer Drugs
Christian G. Hartinger et al.
ORGANOMETALLICS (2012)
Contrasting Reactivity and Cancer Cell Cytotoxicity of Isoelectronic Organometallic Iridium(III) Complexes
Zhe Liu et al.
INORGANIC CHEMISTRY (2011)
Organometallic Half-Sandwich Iridium Anticancer Complexes
Zhe Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Ruthenium(II) arene complexes with oligocationic triarylphosphine ligands: Synthesis, DNA interactions and in vitro properties
Dennis J. M. Snelders et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2011)
Organometallic Iridium(III) Cyclopentadienyl Anticancer Complexes Containing C,N-Chelating Ligands
Zhe Liu et al.
ORGANOMETALLICS (2011)
The determination of oxidative damage in heart tissue of rats caused by ruthenium(II) and gold(I) N-heterocyclic carbene complexes
Osman Ciftci et al.
TOXICOLOGY AND INDUSTRIAL HEALTH (2011)
Group 9 metal-based inhibitors of beta-amyloid (1-40) fibrillation as potential therapeutic agents for Alzheimer's disease
Bradley Yat-Wah Man et al.
CHEMICAL SCIENCE (2011)
Efficient Dipyrrin-Centered Phosphorescence at Room Temperature from Bis-Cyclometalated Iridium(III) Dipyrrinato Complexes
Kenneth Hanson et al.
INORGANIC CHEMISTRY (2010)
Recent developments in ruthenium anticancer drugs
Aviva Levina et al.
METALLOMICS (2009)
Cancer cell killing via ROS To increase or decrease, that is the question
Jie Wang et al.
CANCER BIOLOGY & THERAPY (2008)
Vinyl and ring-opening metathesis polymerization of norbornene with novel half-sandwich iridium(III) complexes bearing hydroxyindanimine ligands
Xia Meng et al.
CHEMICAL COMMUNICATIONS (2008)
KP1019, A New Redox-Active Anticancer Agent - Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
Christian G. Hartinger et al.
CHEMISTRY & BIODIVERSITY (2008)
In Vitro Anticancer Activity and Biologically Relevant Metabolization of Organometallic Ruthenium Complexes with Carbohydrate-Based Ligands
Isabella Berger et al.
CHEMISTRY-A EUROPEAN JOURNAL (2008)
Metal-Ligand Exchange Kinetics in Platinum and Ruthenium Complexes SIGNIFICANCE FOR EFFECTIVENESS AS ANTICANCER DRUGS
Jan Reedijk
PLATINUM METALS REVIEW (2008)
Tuning the hydrophobicity of ruthenium(II)-arene (RAPTA) drugs to modify uptake, biomolecular interactions and efficacy
Claudine Scolaro et al.
DALTON TRANSACTIONS (2007)
From bench to bedside -: preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)
Christian G. Hartinger et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2006)
Synthesis, characterization, and DNA binding of new water-soluble cyclopentadienyl ruthenium(II) complexes incorporating phosphines
A Romerosa et al.
INORGANIC CHEMISTRY (2006)
Interactions of antitumor metallodrugs with serum proteins: Advances in characterization using modern analytical methodology
Andrei R. Timerbaev et al.
CHEMICAL REVIEWS (2006)
Competition between glutathione and guanine for a ruthenium(II) arene anticancer complex: Detection of a sulfenato intermediate
FY Wang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes
C Scolaro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Diorganotin(IV) derivatives of substituted benzohydroxamic acids with high antitumor activity
QS Li et al.
CHEMISTRY-A EUROPEAN JOURNAL (2004)
The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: an NMR evaluation
M Bacac et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2004)
Intratumoral NAMI-A treatment triggers metastasis reduction, which correlates to CD44 regulation and tumor infiltrating lymphocyte recruitment
S Pacor et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Cocultures of metastatic and host immune cells: selective effects of NAMI-A for tumor cells
M Bacac et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Iron chelators in cancer chemotherapy
JL Buss et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2004)
Titanium complexes in cancer treatment
E Meléndez
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2002)
Inhibition of cancer cell growth by ruthenium(II) arene complexes
RE Morris et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Hydrolysis of the tumor-inhibiting ruthenium[lll) complexes Hlm trans-[RnCl4(im)2] and Hlnd trans[RuCl4(ind)2] investigated by means of HPCE and HPLC-MS
A Küng et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2001)
Effects of NAMI-A and some related ruthenium complexes on cell viability after short exposure of tumor cells
A Bergamo et al.
ANTI-CANCER DRUGS (2000)
Synthesis and biological activity of platinum(II) and palladium(II) thiosalicylate complexes with mixed ancillary donor ligands
W Henderson et al.
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS (2000)
分享论文
